Latest Clinical Trials
Pilot programs in New York, Massachusetts, and North Carolina testing babies for DMD may bolster the case for nationwide screening for this rare disease.
Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA) will take center stage early next year at the first in-person annual gathering of the Muscular Dystrophy Association (MDA) since March 2019. The 2022 MDA Clinical & Scientific Conference, set for March 13-16 in Nashville, Tennessee, is expected to attract between 700 and 800 people in…
Families of boys with Duchenne muscular dystrophy have a hard time accessing lifesaving therapies and services in Ukraine, Europe’s poorest country.
My sister, Jamesha, like me, was diagnosed with limb-girdle muscular dystrophy (LGMD) and was dependent on a BiPap machine and wheelchair.
Having a disease like Duchenne muscular dystrophy (DMD) made just searching for a therapist I was comfortable speaking with another quandary.
Since I have limb-girdle muscular dystrophy (LGMD), I do not have a choice but to depend on a wheelchair.
DMD Clinical Insights
We investigate the genetic correction strategies available for DMD patients today and assess their impact on the heart.
We explore the current standard management options for DMD, and contemplate what future therapies will be able to accomplish.
Why do some Duchenne muscular dystrophy clinical trials end in termination? Researchers identified 5 key reasons.
Genetic approaches that target the affected muscle cells in DMD and restore the disrupted reading frame of the dystrophin gene have curative potential.
DMD Conference Coverage